https://www.indianpharmapost.com/akums-surges-in-q3-fy26-with-15-revenue-jump-bags-key-eu-uk-nods-191052026-02-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-nod-to-acrotechs-new-eczema-treatment-191062026-02-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/fortis-healthcare-posts-strong-q3-fy26-growth-revenues-up-175-yoy-191072026-02-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-refuses-to-file-modernas-seasonal-flu-vaccine-application-citing-comparator-issue-191082026-02-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/citius-oncology-expands-lymphir-access-across-europe-via-exclusive-uniphar-deal-191092026-02-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/precision-biosciences-cleared-by-fda-to-launch-groundbreaking-duchenne-gene-editing-trial-191102026-02-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/bioasia-2026-positions-telangana-as-a-global-techbio-powerhouse-191112026-02-14T00:00:00+05:30always0.9